GRIFOLS | Omløpsmidler



Current Assets Endring Dato
Alcon AG USD 6.31B 10M 2024-12
Almirall EUR 693.24M 29.14M 2024-06
Amadeus IT EUR 2.59B 16.9M 2024-12
Amarin USD 650.22M 51.62M 2024-09
AstraZeneca USD 25.83B 1.67B 2024-12
Bayer EUR 34.44B 1.31B 2024-12
Cie Automotive EUR 1.93B 86.4M 2024-12
Demant DKK 9.92B 731M 2024-12
Ence Energia y Celulosa EUR 514.4M 107.4M 2024-09
Essilor EUR 10.04B 28M 2024-12
Ferrovial EUR 7.67B 1.33B 2024-12
Fresenius EUR 11.45B 219M 2024-12
Fresenius Medical Care EUR 7.92B 168.26M 2024-12
Galapagos EUR 3.34B 219.98M 2024-12
Genmab DKK 27.85B 4.16B 2024-12
GlaxoSmithKline GBP 17B 301M 2024-12
GRIFOLS EUR 5.73B 404.28M 2024-12
Hikma Pharmaceutical USD 2.28B 185M 2024-06
Inditex EUR 18.1B 2.04B 2024-10
Merck EUR 13.93B 882M 2024-09
Novartis USD 29.7B 1.56B 2024-12
Philips EUR 10.02B 116M 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 30.08B 589M 2024-06
Smith & Nephew USD 4.42B 37M 2024-12
UCB EUR 4.79B 1.47B 2024-12
Viscofan EUR 761.66M 31.39M 2024-12



GRIFOLS Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.